Literature DB >> 18818893

[Hereditary pancreatic cancer].

N Habbe1, P Langer, D K Bartsch.   

Abstract

An inherited predisposition to pancreatic cancer (PC) is prevalent in about 3% of PC cases and is currently believed to occur in three distinct clinical settings, (1) hereditary tumour predisposition syndromes with an increased risk of PC such as Peutz-Jeghers syndrome and familial atypical multiple mole melanoma, (2) hereditary pancreatitis and cystic fibrosis, in which genetically determined early-age changes of the pancreas can predispose to the development of PC, and (3) familial pancreatic cancer syndrome (FPC). According to a recent consensus conference, high-risk individuals from PC-prone families should be enrolled in board-approved, prospective, controlled screening programs at expert centres. Based on the available data, prophylactic pancreatectomy is not indicated, since the underlying causative gene defect of the FPC syndrome is still unknown and the penetrance of PC in other tumour predisposition syndromes is either low or yet undetermined. In case of the diagnosis of a PC or high-grade precursor lesions, a prophylactic extension of the resection can be considered, since patients with hereditary PC often develop multifocal pancreatic lesions.

Entities:  

Mesh:

Year:  2008        PMID: 18818893     DOI: 10.1007/s00104-008-1559-x

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  58 in total

1.  Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis.

Authors:  H Witt; W Luck; H C Hennies; M Classen; A Kage; U Lass; O Landt; M Becker
Journal:  Nat Genet       Date:  2000-06       Impact factor: 38.330

2.  Advances in counselling and surveillance of patients at risk for pancreatic cancer.

Authors:  Randall E Brand; Markus M Lerch; Wendy S Rubinstein; John P Neoptolemos; David C Whitcomb; Ralph H Hruban; Teresa A Brentnall; Henry T Lynch; Marcia I Canto
Journal:  Gut       Date:  2007-10       Impact factor: 23.059

3.  Insulin secretion in IDDM patients who have undergone successful pancreas-kidney transplantation.

Authors:  P Rigotti; G Pacini; N Baldan; R Nosadini; A Tiengo; E Ancona; A Avogaro
Journal:  Transplant Proc       Date:  1998-03       Impact factor: 1.066

4.  Familial pancreatic cancer (Part 1): Genetic pathology review.

Authors:  H T Lynch; S J Lanspa; R J Fitzgibbons; T Smyrk; M L Fitzsimmons; J McClellan
Journal:  Nebr Med J       Date:  1989-05

5.  Risk factors for cancer in hereditary pancreatitis. International Hereditary Pancreatitis Study Group.

Authors:  A B Lowenfels; P Maisonneuve; D C Whitcomb
Journal:  Med Clin North Am       Date:  2000-05       Impact factor: 5.456

6.  Cancer risk in heterozygotes for ataxia-telangiectasia.

Authors:  B Geoffroy-Perez; N Janin; K Ossian; A Laugé; M F Croquette; C Griscelli; M Debré; B Bressac-de-Paillerets; A Aurias; D Stoppa-Lyonnet; N Andrieu
Journal:  Int J Cancer       Date:  2001-07-15       Impact factor: 7.396

Review 7.  Risk factors for pancreatic cancer.

Authors:  Albert B Lowenfels; Patrick Maisonneuve
Journal:  J Cell Biochem       Date:  2005-07-01       Impact factor: 4.429

8.  Cancer risk in nontransplanted and transplanted cystic fibrosis patients: a 10-year study.

Authors:  Patrick Maisonneuve; Stacey C FitzSimmons; Joseph P Neglia; Preston W Campbell; Albert B Lowenfels
Journal:  J Natl Cancer Inst       Date:  2003-03-05       Impact factor: 13.506

9.  Cancer Incidence in BRCA1 mutation carriers.

Authors:  Deborah Thompson; Douglas F Easton
Journal:  J Natl Cancer Inst       Date:  2002-09-18       Impact factor: 13.506

10.  No evidence for germline mutations of the LKB1/STK11 gene in familial pancreatic carcinoma.

Authors:  Robert Grützmann; Christopher McFaul; Detlef K Bartsch; Mercedes Sina-Frey; Harald Rieder; Rainer Koch; Emma McCarthy; William Greenhalf; John P Neoptolemos; Hans Detlev Saeger; Christian Pilarsky
Journal:  Cancer Lett       Date:  2004-10-08       Impact factor: 8.679

View more
  1 in total

Review 1.  [Familial pancreatic carcinoma].

Authors:  F Ehehalt; R Grützmann
Journal:  Chirurg       Date:  2011-08       Impact factor: 0.955

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.